Inventor · disambiguated record
Qingbei Zeng
Also filed as: ZENG QINGBEI
26 granted patents·10 pending applications·247 citations·filing 2002–2023
96Inventor score
Files withDIZAL JIANGSU PHARMACEUTICAL CO LTD11SCHERING CORP9ASTRAZENECA AB4ANILKUMAR GOPINADHAN N2CHEN KEVIN X2
Top patents by PatentIndex Score
36 records- 0197US7417045B2Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activitySCHERING CORP·Filed 2006·Granted Aug 26, 2008·64 cites·50 claims
- 0293US10822334B2ErbB receptor inhibitorsDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2020·Granted Nov 3, 2020·4 cites·6 claims
- 0390US7105505B2Benzimidazole derivatives useful as histamine H3 antagonistsSCHERING CORP·Filed 2003·Granted Sep 12, 2006·27 cites·22 claims
- 0490US6849621B2Piperidine compoundsSCHERING CORP·Filed 2002·Granted Feb 1, 2005·39 cites·28 claims
- 0588US7799789B2Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activitySCHERING CORP·Filed 2008·Granted Sep 21, 2010·10 cites·37 claims
- 0687US7220735B2Benzimidazolone histamine H3 antagonistsSCHERING CORP·Filed 2003·Granted May 22, 2007·31 cites·18 claims
- 0785US7868005B2Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activitySCHERING CORP·Filed 2006·Granted Jan 11, 2011·9 cites·29 claims
- 0884US8557848B24,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infectionsCHEN KEVIN X·Filed 2007·Granted Oct 15, 2013·10 cites·13 claims
- 0984US7879838B2Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activitySCHERING CORP·Filed 2006·Granted Feb 1, 2011·10 cites·28 claims
- 1083US10898481B2Pyrazine compounds and uses thereofDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2020·Granted Jan 26, 2021·1 cites·6 claims
- 1182US10858365B2Triazolo-pyrimidine compounds and uses thereofDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2020·Granted Dec 8, 2020·1 cites·9 claims
- 1282US8772505B2Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis CCHEN KEVIN X·Filed 2010·Granted Jul 8, 2014·8 cites·14 claims
- 1381US8207170B2Heterocyclic substituted piperazines with CXCR3 antagonist activityKIM SEONG HEON·Filed 2010·Granted Jun 26, 2012·7 cites·1 claims
- 1480US8980920B2Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis CZENG QINGBEI·Filed 2010·Granted Mar 17, 2015·8 cites·8 claims
- 1579US9066979B2Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptorASTRAZENECA AB·Filed 2014·Granted Jun 30, 2015·3 cites·16 claims
- 1679US7868006B2Heterocyclic substituted piperazines with CXCR3 antagonist activitySCHERING CORP·Filed 2006·Granted Jan 11, 2011·3 cites·44 claims
- 1778US8609635B2Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseasesNAIR ANILKUMAR GOPINADHAN·Filed 2011·Granted Dec 17, 2013·8 cites·39 claims
- 1873US2023135068A1Pyrazine compounds and uses thereofDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1971US9375432B2Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptorASTRAZENECA AB·Filed 2015·Granted Jun 28, 2016·1 cites·18 claims
- 2071US8143305B22,3-substituted indole derivatives for treating viral infectionsANILKUMAR GOPINADHAN N·Filed 2008·Granted Mar 27, 2012·2 cites·12 claims
- 2166US11571420B2Pyrazine compounds and uses thereofDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2020·Granted Feb 7, 2023·0 cites·22 claims
- 2263US7238688B2Piperidine compoundsSCHERING CORP·Filed 2004·Granted Jul 3, 2007·1 cites·26 claims
- 2361US11629147B2Triazolo-pyrimidine compounds and uses thereofDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2020·Granted Apr 18, 2023·0 cites·24 claims
- 2461US11447492B2ERBB receptor inhibitorsDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2020·Granted Sep 20, 2022·0 cites·15 claims
- 2561US2025346616A1Rock inhibitors and uses thereofDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 2659US9718806B2Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptorASTRAZENECA AB·Filed 2016·Granted Aug 1, 2017·0 cites·13 claims
- 2756US2018016259A1Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptorASTRAZENECA AB·Filed 2017·Application pending·0 cites
- 2855US2025197377A1Novel pharmaceutical salts and polymorphic forms of an erbb and btk inhibitorDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2950US8614229B2Substituted indole derivatives and methods of use thereofANILKUMAR GOPINADHAN N·Filed 2008·Granted Dec 24, 2013·0 cites·12 claims
- 3050US2022242884A1Dna-dependent protein kinase inhibitorDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 3149US2023122807A1Btk inhibitorsDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 3249US2011104109A1Tetracyclic indole derivatives and their use for treating or preventing viral infectionsBENNETT FRANK·Filed 2008·Application pending·0 cites
- 3345US8901139B2Tricyclic indole derivatives and methods of use thereofVENKATRAMAN SRIKANTH·Filed 2009·Granted Dec 2, 2014·0 cites·19 claims
- 3444US2012157466A1Heterocyclic compounds with cxcr3 antagonist activityZENG QINGBEI·Filed 2007·Application pending·0 cites
- 3541US2014378416A1Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseasesDWYER MICHAEL P·Filed 2012·Application pending·0 cites
- 3641US2015057246A1Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseasesDWYER MICHAEL P·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qingbei Zeng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →